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SUMMARY
Cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) or directly 
reprogrammed from non-myocytes (induced cardiomyocytes, iCMs) are promising sources for 
heart regeneration or disease modeling. However, the similarities and differences between iPSC-
CM and iCM are still unknown. Here we performed transcriptome analyses of beating iPSC-CMs 
and iCMs generated from cardiac fibroblasts (CFs) of the same origin. Although both iPSC-CMs 
and iCMs establish CM-like molecular features globally, iPSC-CMs exhibit a relatively 
hyperdynamic epigenetic status while iCMs exhibit maturation status that more resemble adult 
CMs. Based on gene expression of metabolic enzymes, iPSC-CMs primarily employ glycolysis 
while iCMs utilize fatty acid oxidation as the main pathway. Importantly, iPSC-CMs and iCMs 
exhibit different cell cycle status, alteration of which influenced their maturation. Therefore, our 
study provides a foundation for understanding the pros and cons of different reprogramming 
approaches.
eTOC
Zhou et al. performed gene expression profiling of cardiomyocytes derived from induced 
pluripotent stem cells (iPSC-CMs) or generated through direct reprogramming (induced 
cardiomyocytes, iCMs) from cardiac fibroblasts of the same origin. Comparative analyses revealed 
similarities and differences in the molecular signatures of iPSC-CMs and iCMs.
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INTRODUCTION
Heart disease continues to be the leading cause of death worldwide, partly due to the limited 
therapeutic options. Because mammalian adult heart has little regenerative potential upon 
injury (Laflamme and Murry, 2011; Xin et al., 2013), generation of functional 
cardiomyocytes (CMs) or CM-like cells for replacement therapies offers alternative 
strategies for repairing damaged hearts. Recent advances in cellular reprogramming have 
made it possible to generate autologous CMs by cardiac differentiation of induced 
pluripotent stem cells (iPSC) (Takahashi and Yamanaka, 2006; Zhang et al., 2009) or by 
iCM reprogramming directly from fibroblasts (Ieda et al., 2010; Nam et al., 2013; Qian et 
al., 2012; Song et al., 2012). Efficient differentiation of iPSCs into functional CMs has been 
achieved by stepwise induction that partially recapitulates cardiac differentiation during 
embryonic development (Kattman et al., 2011). These in vitro generated iPSC-CMs are 
relatively immature, reflected at both functional and molecular levels (Lundy et al., 2013; 
Uosaki et al., 2015; Yang et al., 2014). Direct reprogramming of non-myocytes into iCMs 
has been achieved by different combination of factors (Addis et al., 2013; Fu et al., 2013; 
Hirai et al., 2013; Jayawardena et al., 2012; Wada et al., 2013). Considerable progress has 
been made towards improving iCM reprogramming efficiency and understanding the 
underlying molecular mechanisms (Abad et al., 2017; Dal-Pra et al., 2017; Liu et al., 2016a, 
2016b; Mohamed et al., 2016; Muraoka et al., 2014; Nam et al., 2014; Wang et al., 2015a; 
Yamakawa et al., 2015; Zhao et al., 2015; Zhou et al., 2015, 2016). However, it remains 
largely unknown about the cellular and molecular details of iCMs, neither is known about 
the phenotypic similarities or differences between iCMs and iPSC-CMs.
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In this study, we performed a comparative analysis of the molecular characteristics of 
reprogrammed contractile CMs generated by direct reprogramming or differentiation of 
iPSCs from cardiac fibroblasts (CFs) of the same origin. Although both reprogrammed CMs 
possess cardiac features at the transcriptional level, in-depth analyses revealed that iPSC-
CMs more closely resembled embryonic/fetal CMs and possessed a relative hyperdynamic 
epigenetic status when compared to iCMs. Furthermore, a focused analysis of metabolic 
genes and cell cycle regulators indicated that iCMs upregulated genes related to fatty acid 
oxidation and inactive cell cycle status. In contrast, iPSC-CMs exhibited higher expression 
in genes involved in glycolysis and active cell cycle status. We also showed that inhibition of 
cell cycle progression facilitated certain maturation features in iPSC-CMs. Taken together, 
our comparative analyses between iPSC-CMs and iCMs derived from CFs of the same 
origin suggested that reprogrammed CMs generated by different approaches are distinct at 
their molecular characteristics, thereby providing guidance for future clinical applications of 
various cellular reprogramming approaches.
RESULTS
Generation of iPSC-CM and iCM from CF of the Same Origin
To minimize the effects of genetic background, line-to-line variations and epigenetic 
memories of tissue specific fibroblasts, we used CFs of the same origin from αMHC-GFP 
transgenic pups (P1.5) (Ieda et al., 2010). After transduction with OSKM (Oct4, Sox2, Klf4 
and c-Myc) (Takahashi and Yamanaka, 2006), two independent iPSC lines were established 
and subsequently differentiated into CMs. Meanwhile, iCMs were generated by infecting 
CFs with retroviruses expressing a polycistronic Mef2c, Gata4 and Tbx5 transgene (in short 
MGT) (Wang et al., 2015a). Since cardiac differentiation from iPSCs and direct 
reprogramming of iCMs are two different processes, it is difficult to identify CMs of 
comparable stage by marker expression. Furthermore, there was no single marker that 
exclusively labels reprogrammed cardiomyocytes for enrichment; selection based on one 
marker (i.e. αMHC-GFP) may result in exclusion of more fully reprogrammed or 
differentiated myocytes. Therefore, we decided to use all cells that have undergone 
reprogramming/differentiation process at the stage when contractile phenotypes can be 
readily observed for comparative analysis. To this end, we collected beating iPSC-CMs and 
iCMs for microarray analysis and also included endogenous neonatal CFs (neoCFs) and 
CMs (neoCMs) isolated from the same transgenic pups (P1.5) as controls (Figure 1A).
Two iPSC lines named as iPSC1 and iPSC2 with typical pluripotent stem cell morphology 
were manually selected and expanded in feeder free culture system (Figure 1B). 
Pluripotency of both lines is further confirmed by immunocytochemistry (ICC) (Figure 1C) 
and qPCR (Figure 1D) of pluripotent markers. To evaluate the differentiation potential of 
iPSCs, we generated embryoid bodies (EBs) that subsequently differentiated into three germ 
layers expressing germ-layer specific markers (Figures 1E and S1A). We then used the well-
established protocol to differentiate iPSCs into CMs (Kattman et al., 2011), and collected 
beating iPSC-CMs in maturation medium (Movie S1). To obtain beating iCMs, retroviruses 
expressing polycistronic MGT were transduced into primary CFs. These iCMs turned on 
αMHC-GFP reporter, αActinin and cardiac Troponin T (cTnT) at day 14 (Figures 1F and 
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S1B), and then showed spontaneous contractile activity after another 14 days in culture of 
maturation medium (Movie S1). Thus, both types of reprogrammed CMs derived from CFs 
of the same origin were harvested at beating stage from the same maturation medium.
Similar and Different Molecular Features of iPSC-CMs and iCMs
To investigate the global transcription profiles of reprogrammed CMs, we performed 
microarray experiments of iPSC-CMs, iCMs, neoCMs and neoCFs on Agilent mouse 8x60K 
GE 1-color platform. After background correction and normalization, samples were 
clustered by correlation coefficient. According to the heatmap of correlation coefficient, 
biological duplicates of iCMs and iPSC-CMs were highly correlated and grouped together, 
while iCMs and iPSC-CMs showed distinct gene expression profiles (Figure 1G and S2A). 
Then, principal component analysis (PCA) was used to discern variations among samples 
(Figure S2B). PCA analyses showed that PC1 and PC2 reflected the divergence among 
different CMs (Figure 1H), while PC3 mainly accounted for the variations between CMs and 
CFs (Figure 1I) and PC4 revealed the differences between iPSC-CMs derived from the two 
iPSC lines (Figure S2C). Thus, these data indicated that the three types of CMs share 
common gene expression patterns when compared to CFs, but also exhibit specific gene 
signatures for each of them.
To further interrogate the similarities and differences between iPSC-CMs and iCMs, we 
applied Gene Ontology (GO) analysis to characterize differentially expressed genes among 
these cell types. First, we selected significantly up-regulated and down-regulated genes (at 
least 2-fold changes, p < 0.05) in all three types of CMs when compared to CFs (Figure 2A). 
GO results showed that biological processes related to CM were enriched in iCMs, while 
fibroblast related biological processes were suppressed (Figure 2B). Next, to determine the 
unique molecular features of iPSC-CMs or iCMs among three types of CMs, we focused on 
the uniquely expressed genes that displayed at least 2-fold changes (p < 0.05) in expression 
levels when compared to the other two types of CMs and hierarchically clustered these 
genes into groups (Figures 2C and 2E). We found that some categories of iCM-high genes 
partially overlapped with those of fibroblast-high genes (Figures 2B and 2D), suggesting 
residual trace of CF molecular signature in reprogrammed iCMs. Importantly, metabolic-
related genes were uniquely upregulated in iCMs while cell cycle-related genes were 
markedly suppressed in iCMs, suggesting unique metabolic and cell cycle features of iCMs 
(Figure 2D, also see below for more details). Interestingly, we found that the major GO 
terms enriched for iPSC-CM-high genes were “regulation of transcription DNA-templated”, 
“mRNA transport”, “RNA splicing” and “covalent chromatin modification” (Figure 2F, also 
see below for more details), indicating that iPSC-CMs might undergo active transcription 
and have hyperdynamic epigenetic regulation after shortly differentiated from iPSCs 
(Meshorer et al., 2006). Taken together, these data revealed that although reprogrammed 
CMs possess the identity of endogenous neonatal CMs, each type exhibits unique molecular 
features.
Epigenetic Differences between iPSC-CMs and iCMs
GO analysis revealed that genes highly expressed in iPSC-CMs were enriched in epigenetic 
processes including covalent chromatin modification and methylation (Figure 2F), it is thus 
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intriguing to determine the epigenetic status between iPSC-CMs and iCMs. To further 
confirm the enrichment of chromatin regulation genes in iPSC-CMs compared to iCMs or 
neoCMs, we performed gene set enrichment analysis (GSEA) based on GO terms 
“chromatin modification” and “chromatin remodeling”. Consistently, genes in both GO 
terms were positively enriched in iPSC-CMs (Figure 2G). Moreover, western blot analysis 
of a set of histone marks demonstrated higher level of active mark H3K4me3 and lower level 
of repressive mark H3K27me3 in iPSC-CMs compared to iCMs, suggesting the relatively 
active global epigenetic status in iPSC-CMs (Figure 2H). Additionally, we found opposite 
trends in epigenetic re-patterning of H3K4me3 and H3K27me3 along iPSC-CM 
differentiation and iCM reprogramming, when comparing the two differentially 
reprogrammed CMs with their starting cells (Figure 2H). Next, we also determined the 
physical occupancy of H3K4me3 and H3K27me3 at selected loci of cardiac, fibroblast and 
pluripotent genes in iPSC-CMs and iCMs by ChIP-qPCR. At cardiac loci, a higher 
H3K4me3 level was observed in iPSC-CMs (Figure 2I). Examination of fibroblast genes 
revealed higher H3K4me3 in iCMs than in iPSC-CMs (Figure 2I). Meanwhile, ChIP-qPCR 
at pluripotent loci in iPSC-CMs revealed significant increases in both H3K4me3 and 
H3K27me3 levels associated with bivalent modification in iPSCs (Figures 2I and 2J). 
Together, our data are suggestive of distinct patterns of chromatin modifications in 
reprogrammed CMs via the two different routes.
Differed Maturation Statuses of iPSC-CMs and iCMs
Uosaki and colleagues studied transcriptional landscape of CM maturation based on a 
number of published microarray data and identified sets of differentially regulated genes 
during CM maturation (Uosaki et al., 2015). This study prompted us to determine whether 
reprogrammed iCMs and iPSC-CMs represent CMs at different maturation stages. To this 
end, we evaluated the maturation status of reprogrammed CMs with GSEA based on the 
CM-maturation-related gene sets identified by Uosaki et al. Notably, we found that gene sets 
associated with early embryonic (E8–E11) CMs were significantly enriched in iPSC-CMs. 
In contrast, gene sets associated with mature CMs were underrepresented in iPSC-CMs, but 
highly enriched in iCMs (Figure 3A). As expected, gene expression of the control neoCMs 
was positively correlated with that of late embryonic (E16–E18)/neonatal (P3–P10) CMs, 
suggesting its relative mature stage when compared with iPSC-CMs (Figure 3B). 
Interestingly, GSEA of neoCMs and iCMs showed that iCMs displayed a higher correlation 
with gene sets of mature CMs (Adult) than neoCMs (Figure 3C). Based on the pairwise 
comparison of GSEA, we concluded that, among all three types of CMs, iPSC-CMs mostly 
resemble early embryonic CMs and iCMs exhibit molecular signature more similar to that of 
adult CMs (Figure 3D). Next, we asked if iCM reprogramming is a progressing process 
towards or a more direct conversion to adult-like CMs. Thus, MGT- and LacZ (as controls)- 
infected reprogrammed cells at different time points (day 0, 3, 5, 7, 10, 14) were harvested 
and subjected to microarray analysis. Overall PCA plot indicated distinct dynamic changes 
in expression pattern of reprogrammed and control cells over time (Figure S2D). 
Furthermore, gene set enrichment score of early embryonic CM-related genes decreased and 
that of mature CM-associated genes increased along iCM reprogramming, suggesting that 
rapid maturation might occur during iCM induction (Figure 3E). The heatmap of genes 
involved in early and mature gene sets also demonstrated similar changes (Figure 3F). In 
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conclusion, we found that unlike what has been reported for iPSC-CMs, the directly 
reprogrammed iCMs seem to rapidly gain the adult-like CM features at the transcription 
level.
Because recent studies demonstrated that prolonged culturing could enhance PSC-CM 
maturation (Lundy et al., 2013; Uosaki et al., 2015), we intended to further compare long-
term cultured iPSC-CMs to iCMs. We cultured beating iPSC-CMs for additional 20 days 
and collected them for comparative transcriptome analysis. The unsupervised hierarchical 
clustering based on GSEA enrichment score showed that long-term cultured iPSC-CMs are 
more similar to short-term cultured iPSC-CMs in maturation status than iCMs or neoCMs 
(Figure 3G). Of note, long-term culturing strengthened the enrichment score of mature gene 
set, but failed to diminish the enrichment score of early gene set. Consistently, hierarchical 
clustering of maturation-related genes demonstrated similar results (Figure S3A), indicating 
that different maturation routes occur during iCM reprogramming and long-term culture of 
iPSC-CMs.
To further explore distinct features of CMs related to maturation, we evaluated the 
sarcomere structure by ICC of a cardiac Z-disc protein, αActinin, on beating iCMs and 
iPSC-CMs (Figure 4H). Beating iCMs demonstrated repetitive band alignment of organized 
sarcomeres with clear registration across the cell, while beating iPSC-CMs showed less 
organized sarcomeres. Moreover, long-term cultured iPSC-CMs exhibited sarcomere 
structures similar to those in iCMs, indicating that beating iPSC-CMs are maturing in a 
progressive manner that is different from the rapid acquisition of maturation in iCMs. In 
addition, calcium imaging was performed to assess physiological features of iCMs and 
iPSC-CMs. Calcium flux was measured in representative beating cells from each type of 
CMs (Figure 3I, Movie S2). It is noticeable that a higher magnitude of fluorescent intensity 
changes was detected in iCMs than in iPSC-CMs. Taken together, our data demonstrate 
distinct maturation statuses of iCMs and iPSC-CMs that are in parallel exemplified with 
different sarcomere structures and calcium oscillation characteristics. However, long term 
culturing could enhance certain maturation characteristics of iPSC-CMs.
Unique Metabolic and Cell Cycle Signatures in iPSC-CMs and iCMs
According to our GO results, we then compared the expression of genes involved in 
metabolism and cell cycle regulation among various CM types. To explore the expression 
pattern of metabolic genes in iPSC-CMs and iCMs, we selected key genes involved in 
energy metabolism and performed hierarchical clustering (Figure S3B). It is noticeable that 
genes with higher expression in iCMs were mostly grouped in fatty acid (FA) oxidation, 
while most glycolytic genes were expressed at a higher level in iPSC-CMs. Furthermore, to 
identify the metabolic pathway preferentially utilized by each type of CMs, we determined 
the relative expression changes (defined as the fold change of mean expression in iCMs 
versus that in iPSC-CMs) of genes involved in glycolysis, FA oxidation, pentose phosphate 
pathway (PPP) and TCA and highlighted in different colors (Figures 4A and S3C). Genes 
involved in glycolysis, which is the primary means of energy production in early embryonic 
hearts (Lopaschuk and Jaswal, 2010), were expressed at a lower level in iCMs. In contrast, 
genes associated with PPP and FA oxidation were expressed at a higher level in iCMs than 
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those in iPSC-CMs (Figure 4A). In adult CMs, PPP is essential for the preservation of 
contractile function through its role of oxidative defense and FA oxidation is the major 
energy source (Jain et al., 2003; Lopaschuk and Jaswal, 2010). The expression changes of 
key enzymes in these pathways were further validated by qRT-PCR (Figure 4B). We also 
discovered the progressive upregulation of FA oxidation-related genes and downregulation 
of glycolysis genes along iCM induction (Figure S3D). Finally, we determined metabolic 
changes in long-term cultured iPSC-CMs (Figure S3E). Interestingly, we found that long-
term cultured iPSC-CM is grouped together with iCM and neoCM, suggesting enhanced 
maturation at metabolic level resulted from long-term culturing.
Furthermore, we performed gene expression analysis of cell cycle gene set from Kyoto 
Encyclopedia of Genes and Genomes (KEGG), and demonstrated that many of cell cycle-
related genes, including cell-division cycle (Cdc), cyclin and cyclin-dependent kinase (Cdk) 
genes, were repressed in iCMs while positively enriched in iPSC-CMs (Figure 4C). Similar 
results were obtained by GSEA (Figure 4D). In addition, stepwise gene expression changes 
of cell cycle genes were observed along iCM reprogramming (Figure S4A). The cyclins and 
cyclin-dependent kinases are known to be down-regulated in developing CMs (Kang and 
Koh, 1997). Thus, we compared the expression of representative Cdc and Cdk genes 
between iCMs and iPSC-CMs (Figure 4E). Consistently, genes related to G1/S and G2/M 
were repressed in iCMs, suggesting inactive cell cycle in iCMs, reminiscent of the quiescent 
status in adult CMs. In addition, the hierarchical clustering of cell cycle genes demonstrated 
that long-term cultured iPSC-CMs appeared to be similar to iCMs and neoCMs (Figure 
S4B). This observation is consistent with expression changes of the genes related to 
maturation and metabolism.
We were intrigued by the finding that alteration in transcription level of cell cycle genes was 
correlated with changes in expression of maturation genes when comparing iCMs to iPSC-
CMs. Therefore, we sought to determine if cell cycle status of various CMs is related to their 
respective maturation status and if the alteration in cell cycle could influence maturation. 
First, we measured the expression of active cell cycle marker Ki67 in cardiac marker 
αActinin+ iCMs and iPSC-CMs. As expected, 20% of αActinin+ iPSC-CMs expressed 
Ki67, while none of iCMs were Ki67 positive (Figure 4F). To determine the effect of 
alteration in cell cycle on CM maturation, we used Mitomycin C (MMC) to block cell 
division of iPSC-CMs at the time they initiated contraction. After MMC treatment, no 
Ki67+ cells were found in αActinin+ iPSC-CMs (Figure 4G). Importantly, MMC treatment 
increased the percentage of αActinin + cells and promoted the assembly of sarcomeres in 
iPSC-CMs (Figure 4G). In addition, we observed faster beating rate in iPSC-CMs after 
MMC treatment (Movie S1). These data suggest that inhibition of cell cycle progression 
promotes the maturation of iPSC-CMs, at least the phenotypes we examined here. 
Therefore, the distinct cell cycle statuses of iCMs and iPSC-CMs might be one of the 
mechanisms underlying their differed maturation status.
DISCUSSION
iPSC-CMs and iCMs have emerged as appealing cardiomyocyte-like cells for disease 
modeling and potential therapeutic application. Reprogrammed iCMs from CFs showed 
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some cellular features resembling adult-like ventricular cells (Ieda et al., 2010). In our study, 
we found that beating iPSC-CMs are more similar to the early embryonic CMs. Although 
long-term culture promoted organization of sarcomeres and switch of metabolic pathway 
(Figures 3H and S3E), consistent with a previous report (Uosaki et al., 2015), long-term 
cultured iPSC-CMs are limited to an immature stage according to our GSEA results (Figures 
3A and 3G), suggesting that roadblocks exist to block further maturation of iPSC-CMs 
during late stage of iPSC differentiation.
The distinct molecular features between iCMs and iPSC-CMs imply that cardiac 
reprogramming and CM differentiation from iPSC take distinct routes and might also 
involve different signaling cascades to acquire cardiomyocyte fate in a non-myocyte cell. 
The relative rapid acquisition of early maturation features in iCM at reprogramming day 3 
(Figure 3E) might result from the transient high expression of exogenous M/G/T (Ieda et al., 
2010; Wang et al., 2015a). In addition, it is noticeable that iPSC-CMs might possess carry-
over covalent chromatin modifications from iPSCs, suggesting that iPSC-CMs and iCMs 
might carry distinct epigenetic memories (Figures 2G–2J). These traces of epigenetic 
memories in CMs reprogrammed via different routes may be barriers to CM maturation. 
Interestingly, among the differentially expressed genes between iPSC-CMs and iCMs, we 
also identified a large number of noncoding RNAs (Table S1) that could contribute to the 
differed CM features. In spite of the heterogeneity of reprogrammed cells at any stage of 
such unsynchronized process, our genome-wide study using pooled cells still identified 
major molecular features of iCMs and iPSC-CMs, further indicating that the differences in 
their molecular features are significant enough that were not masked by averaging-out of the 
signals. Therefore, our comparative transcriptome profiling of iCMs and iPSC-CMs will be 
useful to help determine under which scenario one or the other type of derived CM is more 
desired for applications such as disease modeling, drug screen or in vivo repair.
EXPERIMENTAL PROCEDURES
Mouse Lines
αMHC promoter driven-GFP transgenic mice were described previously (Ieda et al., 2010). 
Animal care was performed in accordance with the guidelines established by the University 
of North Carolina, Chapel Hill. All mouse protocols were approved by the Institutional 
Animal Care and Use Committee (IACUC), University of North Carolina, Chapel Hill.
Plasmids and Viral Packaging
Retroviral constructs pMXs-Oct4, pMXs-Sox2, pMXs-Klf4 and pMXs-cMyc were used for 
iPSC generation (Takahashi and Yamanaka, 2006). To generate beating iCMs, single 
retroviral construct expressing polycistronic MGT was used (Wang et al., 2015b). The 
protocol of viral packaging is provided in the Supplemental Information.
Isolation of neoCFs, neoCMs, and iCM Reprogramming
Cardiac fibroblast isolation was performed as previously described (Wang et al., 2015b). For 
the isolation of neoCMs, digested heart cells were applied to MACS Dissociator (Miltenyi 
Biotec) and underwent MACS by using Neonatal Cardiomyocyte Isolation Cocktail 
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(Miltenyi Biotec) to collect flow through containing unlabeled CMs. Detailed protocols of 
primary cell culture are available in the Supplemental Information. iCM reprogramming was 
performed as previously described (Zhou et al., 2016). 28 days after viral infection, 
spontaneously beating cells were observed and harvested for RNA extraction, ICC, ChIP, 
Calcium Imaging and Western.
iPSC Generation and Cardiac Differentiation
iPSC lines were generated as previously described (Takahashi et al., 2007) with minor 
modification as described in the Supplemental Information. Cardiac differentiation of iPSCs 
was performed according to a previously described but slightly modified protocol (Kattman 
et al., 2011). Detailed experimental procedures related to iPSC and iPSC-CM are provided 
in the Supplemental Information.
Microarray Analysis
Isolated and purified RNA from indicated samples was applied to Agilent Mouse Gene 
Expression 8x60K Microarray. Data were processed using the limma package from 
Bioconductor (Ritchie et al., 2015). PCA analysis was performed using the ‘prcomp’ 
package in R (www.r-project.org) with the normalized gene expression data. GSEA was 
performed using GSEA 2-2.2.0 software for testing specific gene sets as previously 
described (Lu et al., 2016). For GSEA on more than 2 groups, the enrichment scores were 
calculated using the R package ‘GSVA’ with ‘gsva’ method and default settings 
(Hänzelmann et al., 2013). The gene expression clustering and heatmaps were generated by 
the ‘pheatmap’ package in R. All microarray data reported in this paper have been deposited 
into Gene Expression Omnibus (GEO) with the accession number: GSE 99814
RT-qPCR, ChIP-qPCR and Western Blot
RT-qPCR was performed as described previously (Zhou et al., 2016). ChIP was performed 
using MAGnify ChIP System (ThermoFisher) according to the manufacturers’ instructions 
with α-H3K4me3/α-H3K27me3/α-IgG antibodies. The primer sequences used are provided 
in Supplemental Table S2. Western blotting was performed as described previously (Wang et 
al., 2015a). Antibody information is provided in the Supplemental Information.
ICC, Flow Cytometry and Calcium Imaging
Reprogrammed iCMs, iPSCs and differentiated iPSC-CMs were stained for ICC and flow 
cytometry according to a previously described protocol (Wang et al., 2015a). Calcium 
signals were imaged with Rhod-3 Calcium Imaging Kit (Life Technologies) according to the 
manufacturer’s instructions. Additional details are available in the Supplemental 
Information.
Statistical Analysis
Values were presented as means ± SEM. The unpaired t-test was used to determine the 
significance of differences between two groups. A value of p < 0.05 was considered 
statistically significant (*), a p value of < 0.01 was considered highly significant (**). All 
data are representative of multiple repeated experiments.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Gene expression profiling of iPSC-CM and iCM derived from CF of the same 
origin
• Comparative analyses revealed distinct molecular features between iPSC-CM 
and iCM
• iPSC-CM and iCM differ in gene signature of cell cycle, metabolism and 
chromatin status
• iCM more closely resembles adult CM when compared to iPSC-CM
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Figure 1. Generation, Characterization and Genome-wide Comparison of iCMs and iPSC-CMs
(A) Schematic of comparative transcriptome analyses of iCMs and iPSC-CMs derived from 
CFs of the same origin.
(B) iPSC lines established from CFs.
(C) Immunostaining of iPSCs for SSEA1 and Oct4.
(D) qPCR of pluripotent genes in CF-derived iPSCs. Embryonic stem cell line E14 was used 
as a positive control. n=3, error bars indicated SEM.
(E) ICC for MAP2 (ectoderm), cTnT (mesoderm), αSMA (mesoderm) and PECAM-1 
(endoderm) in differentiated cells derived from iPSCs.
(F) ICC of day 14 iCMs against GFP and αActinin.
(G) Pearson’s correlation heatmap of indicated samples.
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(H,I) PCA of whole genome expression profiles from microarray experiments as listed, with 
a scatter plot of PC1 versus PC2 (H) and a scatter plot of PC2 versus PC3 (I). Samples were 
grouped by different colors as indicated.
All scale bars are 100 μm except in (C) are 200 μm.
See also Figures S1 and S2, Movie S1.
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Figure 2. Genetic and Epigenetic Differences between iCMs and iPSC-CMs
(A,C,E) Differentially expressed genes with at least 2-fold changes in all types of CMs when 
compared with CFs were grouped and clustered as CM-specific genes (A), with at least 2-
fold changes in iCMs when compared with the rest of CMs were grouped and clustered as 
iCM-specific genes (C), with at least 2-fold changes in iPSC-CMs when compared with the 
rest of CMs were grouped and clustered as iPSC-CM-specific genes (E).
(B,D,F) GO terms of biological process enriched in CM-specific (B), iCM-specific (D), 
iPSC-CM-specific (E) genes. Numbers in parenthesis indicate the gene number of each GO 
term. Top panel plot represents enriched functional categories for upregulated genes; bottom 
panel represents enriched functional categories for downregulated genes.
(G) GSEA shows positive correlation of chromatin modification (left) and chromatin 
remodeling (right) genes in iPSC-CMs relative to iCMs (top) or neoCMs (bottom).
(H) Western blot of H3K4me3, H3K27me3, H3K9me2, H3K27ac on iPSCs, iPSC-CMs, 
iCMs and neoCFs. H3 was used as the loading control. Quantification was shown on the 
right.
(I, J) ChIP-qPCR for H3K4me3 (I) or H3K27me3 (J) at indicated gene loci on iCMs and 
iPSC-CMs. Chr8 and Actb were used as negative and positive control respectively in (I). 
Actb was used as a negative control in (J).
n=3 for (H, I, J), error bars indicated SEM; *p < 0.5, **p < 0.01.
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Figure 3. Evaluation of Maturation Status of iCMs and iPSC-CMs
(A–C) GSEA shows enrichment of indicated gene sets associated with early (E8–E11), 
middle (E12–E14), late (E16–E18)/neonatal (P3–P10) and mature (adult heart) stages 
(Uosaki et al., 2015) of heart development (from left to right) in iPSC-CMs versus iCMs 
(A), in iPSC-CMs versus neoCMs (B), in iCMs versus neoCMs (C).
(D) Illustration of distinct maturation stages of heart development corresponding to iPSC-
CMs, iCMs and neoCMs.
(E) Lined scatter plot of the enrichment scores of early, middle, late, mature gene sets 
highlighted by different colors corresponding to time points during iCM reprogramming.
(F) Hierarchical clustering and heatmap of the expression of genes related to different 
developmental stages (green, early genes; purple, mature genes) from D0,3,5,7,10,14 and 
beating iCMs.
(G) Hierarchical clustering of long-term cultured iPSC-CMs with other types of CMs based 
on the enrichment scores of different gene sets indicated in (A). ST, short-term cultured 
iPSC-CMs; LT, long-term cultured iPSC-CMs.
(H) Representative ICC images of sarcomere structure labeled by αActinin in iCMs, iPSC-
CM-ST and iPSC-CM-LT. Top panel is a high-magnification image of the area highlighted 
by rectangle in bottom panel. Scale bars, 10 μm.
(I) Representative calcium transient images and quantitative traces of fluorescence (below) 
in iCMs and iPSC-CMs as indicated. RFU, Relative Fluorescence Units, was calculated by 
dividing background fluorescence intensity.
See also Figures S2 and S3, Movie S2.
Zhou et al. Page 17
Cell Rep. Author manuscript; available in PMC 2017 October 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. Differences in Metabolic and Cell Cycle Status of iCMs and iPSC-CMs
(A) Maps of major metabolic pathways listing key genes encoding metabolic enzymes and 
summarizing relative expression changes of these genes in different CMs. Genes with at 
least 1.5-fold changes in mean expression value when compared between iCMs and iPSC-
CMs were defined as highly expressed genes in iCMs (red) or iPSC-CMs (blue). Unchanged 
genes were marked in white.
(B) qPCR of indicated genes related to glycolysis or FA oxidation/PPP. Fold changes (FC) 
were presented as log2 of expression values in iCMs compared to iPSC1-CMs. n=3, error 
bars indicated SEM.
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(C) Heatmap representation of KEGG_CELL_CYCLE gene set shows its suppression in 
iCMs compared to iPSC-CMs.
(D) GSEA shows positive correlation of cell cycle genes in iPSC-CMs compared to iCMs.
(E) Differentially expressed cyclins and cyclin-dependent kinases when compared between 
iCMs and iPSC-CMs. Bar graph shows log2 fold changes of mean expression value from 
microarray samples. n=4, error bars indicated SEM.
(F) Representative ICC images and quantification for % of αActinin+ cells and % of Ki67+ 
cells out of αActinin+ iPSC-CMs and iCMs. Bottom panels are high magnification images 
for areas indicated in top panels. n=14 for iPSC-CMs and n=7 for iCMs, error bars indicated 
SEM.
(G) Representative ICC images and quantification for % of Ki67+ cells out of αActinin+ 
iPSC-CMs, % of αActinin+ cells and % of cells with sarcomeres out of αActinin+ iPSC-
CMs at day 18 with or without 2-day treatment of 10 μM MMC. n=10, error bars indicated 
SEM; **p < 0.01.
All scale bars are 100 μm.
See also Figures S3 and S4, Movie S1.
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